Cargando…
Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites
The current research and existing facts indicate that type 2 diabetes mellitus (T2DM) is characterized by gut microbiota dysbiosis and disturbed microbial metabolites. Oral glucose-lowering drugs are reported with pleiotropic beneficial effects, including not only a decrease in glucose level but als...
Autores principales: | Wang, Dongmei, Liu, Jieying, Zhou, Liyuan, Zhang, Qian, Li, Ming, Xiao, Xinhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326154/ https://www.ncbi.nlm.nih.gov/pubmed/35909556 http://dx.doi.org/10.3389/fendo.2022.905171 |
Ejemplares similares
-
Improved Glucose and Lipid Metabolism in the Early Life of Female Offspring by Maternal Dietary Genistein Is Associated With Alterations in the Gut Microbiota
por: Zhou, Liyuan, et al.
Publicado: (2018) -
Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis
por: Zhou, Liyuan, et al.
Publicado: (2019) -
Influence of Maternal Inulin-Type Prebiotic Intervention on Glucose Metabolism and Gut Microbiota in the Offspring of C57BL Mice
por: Zhang, Qian, et al.
Publicado: (2019) -
Potential benefits of metformin and pioglitazone combination therapy via gut microbiota and metabolites in high-fat diet-fed mice
por: Wang, Dongmei, et al.
Publicado: (2022) -
The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)